Clinical evaluation of Morgellons disease in a cohort of North American patients

mpost

Veteran Member

Joined : Feb 2015

Posts : 1716

Posted 5/1/2018 5:24 AM (GMT -5)

Clinical evaluation of Morgellons disease in a cohort of North American patients
Published: 2018-04-24
www.pagepress.org/journals/index.php/dr/article/view/7660

"
Of 1000 seropositive LD patients, 60 (6%) were diagnosed with MD. Of these 60 patients, 75% were female and 78% presented in the late disseminated stage of MD. All 60 patients (100%) were seropositive for B. burgdorferi infection. . Tickborne coinfections in these patients included Babesia spp (62%), Bartonella and Rickettsia (25% each), Ehrlichia (15%) and Anaplasma (10%). Helicobacter pylori was detected in 12% of MD patients. In all, 77% of MD patients had one or more coinfections.This study confirms recent findings that MD occurs in a limited subset of LD patients. The clinical and genetic determinants of MD in LD patients require further study."

Full PDF: www.pagepress.org/journals/index.php/dr/article/download/7660/7272

Post Edited (mpost) : 5/1/2018 4:28:06 AM (GMT-6)

ChickenArise

Veteran Member

Joined : Nov 2015

Posts : 1553

Posted 5/1/2018 8:52 AM (GMT -5)

Good find. I wish patients were analyzed for fungal infections as well as bacterial but the medical industry almost completely continues to ignore this in both Morgellons and Lyme. I believe it is key to many illnesses including Autism. It may be the key to cancer as well.

As I recently posted in my blog I believe this is critical to finding a cure.

With the advent of the CDC's Dearborn incident I can see why it is being ignored as to Lyme, especially if OspA or any fungal antigen like it plays the major role that has been implicated by the Lyme Cryme crew. To date I have every reason to believe it does.

✚ New Topic ✚ Reply